Fresh2 Group Ltd.

NASDAQ : FRES

Fresh2 Group Limited, a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People's Republic of China. It also offers physical checkup packages, as well as technology services comprising market research, designing, coding, developing, testing, etc. In addition, the company sells genetic testing kits and skin-care products; and owns core technology platforms, as well as engages in technology development and product distribution. Further, it operates an e-commerce platform that connects food suppliers and supermarket operators and restaurant owners. The company was formerly known as AnPac Bio-Medical Science Co., Ltd. and changed its name to Fresh2 Group Limited in April 2023. The company was incorporated in 2010 and is based in New York, New York.

Information

Sector
Healthcare
Industry
Biotechnology
Type
Depositary Receipt
Country
United States

Price

USD 1.51

Symbol

FRES

Type

Depositary Receipt

Previous Close

:

1.82

52 Week Range

:

1.18 - 20.30

Volume

:

65,142.00

Average Volume

:

167,814.00

High

:

1.57

Low

:

1.40

Change

:

-0.31

Percent change (%)

:

-17.03

Disclaimer: Stakeville is a simulation trading game. All trades and stock prices are fictional and do not reflect real-world markets. This game is for entertainment purposes only and does not involve real financial transactions. Read more...